← All companies

TARA

Protara Therapeutics, Inc.

TARA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$3.97

-0.06 -1.49%

Key statistics

from XBRL data in SEC filings

Market cap

$223M

Revenue (TTM)

$2.95M

Net income (TTM)

-$63.3M

EPS (TTM)

$-1.36

P/E ratio

—

Dividend yield

—

Free cash flow

-$56.5M

Cash

$14.7M

Total assets

$192M

Gross margin

—

52-week range

$2.97 – $7.82

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jun 29, 2026 8-K Shareholder vote results Jun 15, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Regulation FD disclosure Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Regulation FD disclosure; Other events Feb 24, 2026 8-K Other events Dec 15, 2025 8-K Entered a material agreement Dec 8, 2025 8-K Regulation FD disclosure; Other events Dec 3, 2025 8-K Regulation FD disclosure; Other events Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Shareholder vote results Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Regulation FD disclosure; Other events Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release) Mar 5, 2025 8-K Regulation FD disclosure; Other events Jan 13, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 11, 2024 8-K Regulation FD disclosure; Other events Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Apr 5, 2024 8-K Director or officer change Mar 18, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release) Mar 13, 2024 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Results of operations (earnings release) Nov 3, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Results of operations (earnings release) Aug 3, 2023